These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 23010745)

  • 21. Thrombocytopenia: Evaluation and Management.
    Gauer RL; Whitaker DJ
    Am Fam Physician; 2022 Sep; 106(3):288-298. PubMed ID: 36126009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetic/Pharmacodynamic Modelling and Simulation of Lusutrombopag, a Novel Thrombopoietin Receptor Agonist, for the Treatment of Thrombocytopenia in Patients with Chronic Liver Disease Undergoing Invasive Procedures.
    Katsube T; Shimizu R; Fukuhara T; Kano T; Wajima T
    Clin Pharmacokinet; 2019 Nov; 58(11):1469-1482. PubMed ID: 31055790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lusutrombopag Reduces Need for Platelet Transfusion in Patients With Thrombocytopenia Undergoing Invasive Procedures.
    Hidaka H; Kurosaki M; Tanaka H; Kudo M; Abiru S; Igura T; Ishikawa T; Seike M; Katsube T; Ochiai T; Kimura K; Fukuhara T; Kano T; Nagata T; Tanaka K; Kurokawa M; Yamamoto K; Osaki Y; Izumi N; Imawari M
    Clin Gastroenterol Hepatol; 2019 May; 17(6):1192-1200. PubMed ID: 30502505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coagulation abnormalities in patients with chronic liver disease in Pakistan.
    Siddiqui SA; Ahmed M; Ghani MH; Memon MA; Mustafa G; Ghori MA
    J Pak Med Assoc; 2011 Apr; 61(4):363-7. PubMed ID: 21465974
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of thrombocytopenia between patients with non-alcoholic fatty liver disease and those with hepatitis C virus-related chronic liver disease.
    Kinoshita N; Shima T; Terasaki K; Oya H; Katayama T; Matsumoto J; Mitsumoto Y; Mizuno M; Mizuno C; Hirohashi R; Sakai K; Okanoue T
    Hepatol Res; 2022 Aug; 52(8):677-686. PubMed ID: 35543116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid platelet count improvement in chronic hepatitis C patients with thrombocytopenia receiving direct-acting antiviral agents.
    Chen YC; Tseng CW; Tseng KC
    Medicine (Baltimore); 2020 May; 99(19):e20156. PubMed ID: 32384505
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunosuppressive treatment combined with nucleoside analog is superior to nucleoside analog only in the treatment of severe thrombocytopenia in patients with cirrhosis associated with hepatitis B in China: A multicenter, observational study.
    Zhang XH; Feng R; Xu LP; Jiang Q; Jiang H; Fu HX; Liu H; Niu T; Wang X; Hu JD; Jiang M; Wang Z; Wang JW; Ma H; Xie YD; Zhu XL; Wang H; Wei L; Huang XJ
    Platelets; 2015; 26(7):672-9. PubMed ID: 25397356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Thrombopoietin Receptor Agonist Lusutrombopag Is Effective for Patients with Chronic Liver Disease and Impaired Renal Function.
    Takeuchi H; Furuichi Y; Yoshimasu Y; Kasai Y; Abe M; Sugimoto K; Itoi T
    J Nippon Med Sch; 2021 Jan; 87(6):325-333. PubMed ID: 32238734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low Fibrinogen Levels Are Associated with Bleeding After Varices Ligation in Thrombocytopenic Cirrhotic Patients.
    Giannini EG; Giambruno E; Brunacci M; Plaz Torres MC; Furnari M; Bodini G; Zentilin P; Savarino V
    Ann Hepatol; 2018 Jun; 17(5):830-835. PubMed ID: 30145561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and efficacy of warfarin in patients with moderate thrombocytopenia.
    Lai YF; Goh DYT; How SY; Lee KY; Tham VWP; Kong MC; Tan CW; Ng HJ
    Thromb Res; 2017 Jul; 155():53-57. PubMed ID: 28499153
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bleeding after invasive procedures is rare and unpredicted by platelet counts in cirrhotic patients with thrombocytopenia.
    Napolitano G; Iacobellis A; Merla A; Niro G; Valvano MR; Terracciano F; Siena D; Caruso M; Ippolito A; Mannuccio PM; Andriulli A
    Eur J Intern Med; 2017 Mar; 38():79-82. PubMed ID: 27989373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of Baseline Thrombocytopenia on Bleeding and Mortality After Percutaneous Coronary Intervention.
    Ito S; Watanabe H; Morimoto T; Yoshikawa Y; Shiomi H; Shizuta S; Ono K; Yamaji K; Soga Y; Hyodo M; Shirai S; Ando K; Horiuchi H; Kimura T
    Am J Cardiol; 2018 Jun; 121(11):1304-1314. PubMed ID: 29628128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thrombocytopenia in the critically ill: prevalence, incidence, risk factors, and clinical outcomes.
    Williamson DR; Lesur O; Tétrault JP; Nault V; Pilon D
    Can J Anaesth; 2013 Jul; 60(7):641-51. PubMed ID: 23615940
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fecal blood loss: A quantitative method of evaluating hemostasis in patients with thrombocytopenia.
    Slichter SJ; Gernsheimer T; LeBlanc R; Townsend-McCall D; Jones MK; Cuaron L; Bolgiano D
    Transfusion; 2021 Feb; 61(2):393-403. PubMed ID: 33166412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thrombocytopenia in patients in the medical intensive care unit: bleeding prevalence, transfusion requirements, and outcome.
    Strauss R; Wehler M; Mehler K; Kreutzer D; Koebnick C; Hahn EG
    Crit Care Med; 2002 Aug; 30(8):1765-71. PubMed ID: 12163790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessing in-hospital cardiovascular, thrombotic and bleeding outcomes in patients with chronic liver disease undergoing left ventricular assist device implantation.
    Grant JK; Ebner B; Vincent L; Maning J; Olorunfemi O; Olarte NI; Colombo R; Munagala M; Chaparro S
    Thromb Res; 2021 Jun; 202():184-190. PubMed ID: 33892219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of and risk of bleeding during pegylated interferon plus ribavirin treatment in HIV/HCV-coinfected patients with pretreatment thrombocytopenia.
    Mira JA; Neukam K; López-Cortés LF; Rivero-Juárez A; Téllez F; Girón-González JA; de los Santos-Gil I; Ojeda-Burgos G; Merino D; Ríos-Villegas MJ; Collado A; Torres-Cornejo A; Macías J; Rivero A; Pérez-Pérez M; Pineda JA; ;
    Eur J Clin Microbiol Infect Dis; 2015 Sep; 34(9):1879-84. PubMed ID: 26115631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Real-life experience of lusutrombopag for cirrhotic patients with low platelet counts being prepared for invasive procedures.
    Takada H; Kurosaki M; Nakanishi H; Takahashi Y; Itakura J; Tsuchiya K; Yasui Y; Tamaki N; Takaura K; Komiyama Y; Higuchi M; Kubota Y; Wang W; Okada M; Shimizu T; Watakabe K; Enomoto N; Izumi N
    PLoS One; 2019; 14(2):e0211122. PubMed ID: 30768601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical Implications of Thrombocytopenia at Cardiogenic Shock Presentation: Data from a Multicenter Registry.
    Lee HH; Hong SJ; Ahn CM; Yang JH; Gwon HC; Kim JS; Kim BK; Ko YG; Choi D; Hong MK; Jang Y
    Yonsei Med J; 2020 Oct; 61(10):851-859. PubMed ID: 32975059
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term outcomes associated with hospital acquired thrombocytopenia among patients with non-ST-segment elevation acute coronary syndrome.
    Vora AN; Chenier M; Schulte PJ; Goodman S; Peterson ED; Pieper K; Jolicoeur ME; Mahaffey KW; White H; Wang TY
    Am Heart J; 2014 Aug; 168(2):189-96.e1. PubMed ID: 25066558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.